Another brick in the wall: adrenomedullin and prognosis in community-acquired pneumonia

Krüger Stefan, Frechen Dirk

Source: Eur Respir J 2012; 39: 1060-1061

Journal Issue: May

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Krüger Stefan, Frechen Dirk. Another brick in the wall: adrenomedullin and prognosis in community-acquired pneumonia. Eur Respir J 2012; 39: 1060-1061

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Prognosis of ventilator-associated pneumonia: what lies beneath Source: Eur Respir J 2011; 37: 486-488 Year: 2011
The role of endothelin-1 in hospitalized patients with community-acquired pneumonia. Source: International Congress 2019 – Mechanisms underlying respiratory infection Year: 2019
Inflammatory pattern in bacteriemic community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011
Value of bacteraemia as an unfavourable prognostic factor for community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 350s Year: 2006
Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia? Source: Eur Respir Rev, 29 (157) 200023; 10.1183/16000617.0023-2020 Year: 2020
Copeptin and prognosis of ventilator-associated pneumonia Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008
Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015
Corticosteroids and community-acquired pneumonia Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007
Risk factors for pulmonary tuberculosis in community-acquired pneumonia Source: Eur Respir J 2014; 43: 1214 Year: 2014
Risk factors for pulmonary tuberculosis in community-acquired pneumonia Source: Eur Respir J 2014; 43: 1213 Year: 2014
Clinical failure in community-acquired pneumonia Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases Year: 2014
The lung bacterial microbiome in community-acquired and nosocomial pneumonia Source: Eur Respir Monogr 2019; 83: 188-194 Year: 2019
Cardiovascular consequences of community-acquired pneumonia and other pulmonary infections Source: Eur Respir Monogr 2020; 88: 212-228 Year: 2020
Etiology pathogens structure in community-acquired pneumonias and COPD exacerbations Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011
Prediction of prognosis in healthcare-associated pneumonia Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012
Thrombocytosis is a marker of poor outcome in community-acquired pneumonia Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012
Adrenal function is related to prognosis in moderate community-acquired pneumonia Source: Eur Respir J 2010; 36: 615-621 Year: 2010
Usefullness of CPR and PCT in the etiological diagnosis of community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011
Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Source: Eur Respir J 2009; 33: 153-159 Year: 2009
Severe community-acquired pneumonia Source: Eur Respir Monogr 2016; 74: 101-116 Year: 2016